Question

Difficulty: HardSomatic Symptom and Eating Disorders

A 19-year-old female sophomore college student presents to the university health clinic seeking help for worsening sadness, low energy, and difficulty focusing on her coursework over the past four months. During the interview, she tearfully admits to intense dissatisfaction with her body weight. She describes periods where she consumes unusually large amounts of food in secret, immediately followed by the use of laxatives and self-induced vomiting. This cycle occurs almost daily. Her current body mass index is 22.1 kg/m2kg/m^2. Vital signs reveal a blood pressure of 105/65 mm Hg and a heart rate of 88/min. Physical examination notes bilateral parotid gland enlargement and abrasions on the dorsal aspect of her hands.

Basic metabolic panel results:
ParameterValueReference Range
Sodium139 mEq/L136-145 mEq/L
Potassium3.0 mEq/L3.5-5.0 mEq/L
Chloride90 mEq/L95-105 mEq/L
Bicarbonate33 mEq/L22-28 mEq/L
Arterial blood gas on room air:
ParameterValueReference Range
pH7.497.35-7.45
PaCO2PaCO_246 mm Hg35-45 mm Hg
PaO2PaO_292 mm Hg75-105 mm Hg

The patient asks about starting a medication to help with her mood and eating patterns. Which of the following is the most accurate statement regarding this patient's clinical picture and pharmacological management?

  1. Bupropion is absolutely contraindicated due to a significantly increased risk of precipitating generalized seizures.Answer
  2. B
    The arterial blood gas results indicate an uncompensated primary metabolic alkalosis with a concurrent primary respiratory acidosis.
  3. C
    Fluoxetine therapy is strongly discouraged as it has been shown to paradoxically increase the frequency of binge-eating episodes.
  4. D
    The laboratory findings are consistent with a state of secondary hypoaldosteronism driven by chronic intravascular volume depletion.
  5. E
    Selective serotonin reuptake inhibitor monotherapy should be avoided to prevent a treatment-emergent manic episode.

Answer

Bupropion is absolutely contraindicated due to a significantly increased risk of precipitating generalized seizures.
The correct answer identifies that bupropion is strictly contraindicated in patients with eating disorders. This patient's presentation of recurrent binge eating, compensatory purging, normal body mass index, parotid gland enlargement, and Russell sign (hand abrasions) is diagnostic for bulimia nervosa. Furthermore, her laboratory results reveal a hypokalemic, hypochloremic metabolic alkalosis—a hallmark of chronic vomiting. Bupropion is an atypical antidepressant that lowers the seizure threshold in a dose-dependent manner. In patients with bulimia nervosa or anorexia nervosa, underlying electrolyte abnormalities (such as hypokalemia and hyponatremia) already predispose them to a lowered seizure threshold. Consequently, administering bupropion in this population significantly increases the risk of generalized tonic-clonic seizures and represents an absolute contraindication.

Step-by-Step Solution

1
Establish the primary psychiatric diagnosis based on the clinical history and physical examination.
The patient's recurrent binge eating followed by compensatory purging, normal BMI, parotid hypertrophy, and dorsal hand abrasions (Russell sign) confirm the diagnosis of bulimia nervosa.
Accurate diagnosis is required to select appropriate pharmacotherapy and anticipate specific medical complications.
2
Interpret the basic metabolic panel and arterial blood gas to determine the patient's physiological status.
The patient has a hypokalemic, hypochloremic metabolic alkalosis (HCO3−HCO_3^- 33 mEq/L, pH 7.49). Using the compensatory formula for metabolic alkalosis ("Expected"  PaCO2=40+0.7×ΔHCO3−"Expected"\; PaCO_2 = 40 + 0.7 \times \Delta HCO_3^-), the expected PaCO2PaCO_2 is roughly 46.3 mm Hg. Her PaCO2PaCO_2 of 46 mm Hg represents appropriate respiratory compensation.
Vomiting depletes fluid, H+H^+, Cl−Cl^-, and K+K^+, leading to characteristic acid-base derangements that can lower the seizure threshold and cause arrhythmias.
3
Identify pharmacological contraindications specific to the patient's diagnosis and metabolic state.
While fluoxetine is first-line for bulimia, bupropion is strictly contraindicated.
Bupropion lowers the seizure threshold in a dose-dependent manner. This risk is synergistically amplified by the electrolyte disturbances (like hypokalemia) seen in bulimia nervosa, making it highly epileptogenic in this population.

Key Concept

Pharmacological management and physiological complications of bulimia nervosa
Estimated Time:1m 30s
Rate this question